New CCR2 receptor antagonists and uses thereof

Details for Australian Patent Application No. 2010332969 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Ebel, Heiner; Frattini, Sara; Gerlach, Kai; Giovannini, Riccardo; Hoenke, Christoph; Mazzaferro, Rocco; Santagostino, Marco; Scheuerer, Stefan; Tautermann, Christofer; Trieselmann, Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2010332969

PCT Pub. Number WO2011/073154

Priority 09179555.9 17.12.09 EP; 10162621.6 12.05.10 EP

Filing date 13 December 2010

Wipo publication date 23 June 2011

International Classifications

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/073154 Priority application(s): WO2011/073154

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332971-Integrated reactance module

2010332964-Method for dosing an urea based reducing agent into a gas exhaust stream